TAUB REBECCA received a stock award from MADRIGAL PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/18/2026ACC: 0001628280-26-044346
Director
Since Mar 2026
+1.22K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.22K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+454.00
Price / share
—
Trade value
—
% of position
0.1%
6/17/2026
452.21K→452.67K
Total
Net shares
+454.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2026 | A · Award | +454.00 | — | — | 0.1% | 452.21K | 452.67K |
| Total | +454.00 | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
766.00 shares
Shares
+766.00
Strike price
499.86
Held after
766.00
Exercisable
—
6/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock766.00 shares | 6/17/2026 | A · Award | +766.00 | 499.86 | — | 766.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned655.54K
Total
655.54K indirect655.54K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 655.54K | Indirect |
| Total | 655.54K | 655.54K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported